The use of the somatostatin analogue octreotide for the conservative management of symptomatic cholecystocolonic fistula: a case report.
Cholecystocolonic fistula
Chronic diarrhoea
Octreotide
Somatostatin analogues
Journal
Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
26
10
2018
medline:
5
2
2019
entrez:
26
10
2018
Statut:
ppublish
Résumé
An 84-year-old woman presented with acute worsening of diarrhoea for a few weeks, with a background of chronic diarrhoea over the past 12 months accompanied by weight loss. Computed tomography during this admission revealed air in the biliary tree and resolution of gallstones in keeping with a cholecystocolonic fistula. Owing to her comorbidities, surgical management was deemed not to be the best option. She was trialled on octreotide, a somatostatin analogue, which effectively resolved her symptoms. This case presents an effective and novel method of managing cholecystocolonic fistulas conservatively in a patient where medical therapy is the ceiling of care.
Identifiants
pubmed: 30354187
doi: 10.1308/rcsann.2018.0192
pmc: PMC6351876
doi:
Substances chimiques
Gastrointestinal Agents
0
Octreotide
RWM8CCW8GP
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e59-e61Références
Aliment Pharmacol Ther. 2001 Dec;15(12):1889-97
pubmed: 11736719
Gut. 2001 Dec;49 Suppl 4:iv11-21
pubmed: 11878789
J Hepatobiliary Pancreat Surg. 2009;16(1):8-18
pubmed: 19089311
Hong Kong Med J. 2010 Oct;16(5):406-8
pubmed: 20890009
Hawaii J Med Public Health. 2012 Jun;71(6):155-7
pubmed: 22787563